Distribution of dexamethasone and preservation of inner ear function following intratympanic delivery of a gel-based formulation.
about
Intracochlear drug delivery in combination with cochlear implants : Current aspectsHearing Changes After Intratympanically Applied Steroids for Primary Therapy of Sudden Hearing Loss: A Meta-analysis Using Mathematical Simulations of Drug Delivery Protocols.[Intracochlear drug delivery in combination with cochlear implants : Current aspects].Controlled release dexamethasone implants in the round window niche for salvage treatment of idiopathic sudden sensorineural hearing lossRound-window delivery of neurotrophin 3 regenerates cochlear synapses after acoustic overexposure.Sustained release of triamcinolone acetonide from an intratympanically applied hydrogel designed for the delivery of high glucocorticoid doses.Dexamethasone uptake in the murine organ of Corti with transtympanic versus systemic administration.Systemic effects of intratympanic dexamethasone therapyDexamethasone released from cochlear implant coatings combined with a protein repellent hydrogel layer inhibits fibroblast proliferation.A novel chitosan-hydrogel-based nanoparticle delivery system for local inner ear application.Intratympanic dexamethasone in sudden sensorineural hearing loss: A systematic review and meta-analysis.Perilymph pharmacokinetics of markers and dexamethasone applied and sampled at the lateral semi-circular canal.Developments in delivery of medications for inner ear disease.The role of intracochlear drug delivery devices in the management of inner ear disease.How long should patients remain in the supine treatment position after intratympanic dexamethasone injection?A novel vehicle for local protein delivery to the inner ear: injectable and biodegradable thermosensitive hydrogel loaded with PLGA nanoparticles.Preoperative steroids for hearing preservation cochlear implantation: A review.Dexamethasone levels and base-to-apex concentration gradients in the scala tympani perilymph after intracochlear delivery in the guinea pig.Evaluation of intratympanic formulations for inner ear delivery: methodology and sustained release formulation testing.Assessment of PLGA-PEG-PLGA copolymer hydrogel for sustained drug delivery in the ear.Preclinical evaluation of thermoreversible triamcinolone acetonide hydrogels for drug delivery to the inner ear.Nanomedicine for Inner Ear Diseases: A Review of Recent In Vivo Studies.Communication pathways to and from the inner ear and their contributions to drug delivery.Effects of dexamethasone on intracochlear inflammation and residual hearing after cochleostomy: A comparison of administration routes.A Polymer-Based Extended Release System for Stable, Long-term Intracochlear Drug Delivery
P2860
Q30313632-55F1D4DB-2926-4D8E-BC76-8C57172A2F37Q30313800-A0C870B4-FA90-44DC-9EA9-2F5F5C2992CCQ30313814-8744371A-A171-4704-9C45-A3807DFEF064Q30317432-27EC0F41-CCCD-48E6-86DE-6F830F05A06BQ30384995-70F8B1D6-DBCE-4FD6-9EAE-2DEDC4D4D027Q30392675-78913FA2-50BD-48DF-9895-0301824B7590Q30454645-675D0ADC-CE28-4183-A01D-31589BF2940EQ34051914-162AB70A-61C8-4660-8C74-C0BDCAA30DB4Q34637454-1F8883E1-3A24-457C-AA91-68600C23529DQ35193795-996DB092-5B7C-4077-BA80-24DFBE819680Q36197780-0549BC62-AE4D-403F-B9B9-3D70F183C6D9Q36421098-90701A69-4AFE-43FB-A594-2C6F757CE05EQ38096427-E6B5E00C-75FB-435E-A1BB-B81B8F202C70Q38262931-5977F99B-0F19-4675-84CF-E136159D2A0AQ38435372-230251F3-4050-4C80-95D4-910BAA87C790Q38603485-6EFEC885-FF86-4B85-B527-F9C54412EBD8Q38749399-AC6B6F9D-4B7A-46C8-B7EB-665921E86EEAQ41810387-5EF6EC38-D93B-4BA7-9124-17D8C674DF4FQ41856899-67D5F122-6BC2-4B4D-BF4F-368A7A216789Q42575114-F1E3F2BD-94FA-4DD1-8190-7B658784B9D9Q42727024-FF2BDE79-3FBF-427E-BD51-E22419D6D588Q46425471-F540040F-36A3-4739-8B37-15FED59F1DC6Q47896229-450E64F6-49E0-4D0C-BCF4-10C1796222DEQ53076432-3F7643F7-6D14-4D6F-B879-EA3DADCF01CBQ57095355-6ABD7B0A-3052-4D64-B641-54362C9F19CA
P2860
Distribution of dexamethasone and preservation of inner ear function following intratympanic delivery of a gel-based formulation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Distribution of dexamethasone ...... ry of a gel-based formulation.
@ast
Distribution of dexamethasone ...... ry of a gel-based formulation.
@en
type
label
Distribution of dexamethasone ...... ry of a gel-based formulation.
@ast
Distribution of dexamethasone ...... ry of a gel-based formulation.
@en
prefLabel
Distribution of dexamethasone ...... ry of a gel-based formulation.
@ast
Distribution of dexamethasone ...... ry of a gel-based formulation.
@en
P2093
P2860
P356
P1476
Distribution of dexamethasone ...... ery of a gel-based formulation
@en
P2093
Carl LeBel
Fabrice Piu
Jared Hartsock
Stefan Plontke
P2860
P304
P356
10.1159/000322504
P50
P577
2010-12-19T00:00:00Z